Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

How Sports Stars and Drugs Keep Getting Reinvented
Reinvention is everywhere. Products get updated, industries change course, and ideas we once treated as finished suddenly come back in a new form. Something that felt permanent five years ago can look completely different today, redesigned for a new audience or a new moment. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Novogene Europe Expands Single-Cell Sequencing Capability at Cambridge Omics Centre
Monday, July 27, 2026
Novogene Europe announced that it has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre. This expansion brings single-... read more
Pace Life Sciences Announces Compliant FDA Inspection of Operations in Research Triangle Park, NC
Monday, July 27, 2026
Pace® Life Sciences announced the successful completion of an FDA inspection of its Small Molecule Center of Excellence in Research Triangle Park, ... read more
CluePoints Appoints Martin Magazzolo as Chief Commercial Officer
Monday, July 27, 2026
CluePoints has appointed Martin (Marty) Magazzolo as its new Chief Commercial Officer (CCO). Marty will lead CluePoints' global commercial ... read more
Bora, Onconic Ink Manufacturing Deal for U.S. JAQBO Clinical Program
Thursday, July 23, 2026
Bora Pharmaceuticals and Onconic Therapeutics have signed a manufacturing agreement to support the U.S. clinical development of JAQBO tablets, a ... read more
ImmuPharma Selects Thermo Fisher Scientific Drug Product CDMO for Kapiglucagon Program
Wednesday, July 22, 2026
The selection of Thermo Fisher represents an important Chemistry, Manufacturing and Controls (“CMC”) milestone for the Kapiglucagon program and is ... read more